InvestorsHub Logo
Followers 7
Posts 255
Boards Moderated 0
Alias Born 06/26/2010

Re: None

Monday, 07/30/2012 7:49:34 PM

Monday, July 30, 2012 7:49:34 PM

Post# of 129051
Cannabis Science Releases New Photos on the Continual Improvement of Patient Three
http://www.marketwatch.com/story/cannabis-science-releases-new-photos-on-the-continual-improvement-of-patient-three-who-suffers-from-squamous-cell-carcinoma-2012-07-30
Cannabis Science CBIS -5.07% , a pioneering U.S. Biotech Company developing pharmaceutical products for global public health challenges is pleased to report on the continued progress made by Patient Three who suffers from an extremely severe case of chemo- and radiation-resistant squamous cell carcinoma.

Cannabis Science has been working closely with Patient Three for some time. He has been self-administering a topical cannabis-based extract, and continues to see reduction of the tumor mass along with apparent healing. The patient's oncologist is impressed with the improvement made from the topical application of CSSC-1.

The treatment has reduced the tumor mass down to the exposed skull, as seen in the lesion on the left side of the patient's head. There has also been a significant reduction of the tumor mass on the right side of the patient's head, and the outer perimeter of the tumor itself is decreasing. The growth of new tissue is readily seen.

An HIV physician with extensive oncology experience had the opportunity to view the photo-documentation from Patient 3 and commented, "How come I know nothing about this? We need to do trials now."

Dr. Melamede however has noted that the healing process is taking longer now that the tumor has been significantly reduced in size. "Perhaps now that the tumor burden has been significantly reduced, surgery to close the wound might be a sensible option. We look forward hearing his oncologist's opinion after his next visit in August."

The new photos of Patent 3 can be seen on the Cannabis Science website www.cannabisscience.com , "View Images of 3rd Self-Medicated Patient & His Apparent Success." More news on this 3rd patient, as well the other patients can be viewed on the Cannabis Science website, www.cannabisscience.com by clicking on the breaking news button where you will find all the cancer related and updated patient news.

About Cannabis Science, Inc.

Cannabis Science, Inc. is conducting cannabinoid research and development for unmet medical needs. The Company works with leading experts in HIV drug development, medicinal characterization, and clinical research to develop, produce, and commercialize Phytocannabinoid-based pharmaceutical products.

Cannabis Science is currently working with CBR International to develop a Pre-IND Application to the FDA that focuses on the use of CS-S/BCC-1 topical cannabis-based preparations for the treatment of basal and squamous cell carcinomas.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.